Starling Oncology, Inc. Shares Authorized
Starling Oncology, Inc. (DFPH) had Shares Authorized of 500.00 million shares as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Common Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:CommonStockSharesAuthorized · last filed 2026-08-06
- 2026-06-30: Common Stock, Shares Authorized 500.00M shares.
- 2026-03-31: Common Stock, Shares Authorized 500.00M shares.
- 2025-12-31: Common Stock, Shares Authorized 500.00M shares.
- 2025-09-30: Common Stock, Shares Authorized 500.00M shares.
| Period end | Common Stock, Shares Authorized |
|---|---|
| 2026-06-30 | 500.00M shares 10-Q · filed 2026-08-06 |
| 2026-03-31 | 500.00M shares 10-Q · filed 2026-05-07 |
| 2025-12-31 | 500.00M shares 10-Q · filed 2026-08-06 |
| 2025-09-30 | 500.00M shares 10-Q · filed 2025-11-13 |
| 2025-06-30 | 500.00M shares 10-Q · filed 2025-08-13 |
| 2025-03-31 | 500.00M shares 10-Q · filed 2025-05-14 |
| 2024-12-31 | 500.00M shares 10-K · filed 2026-03-12 |
| 2024-09-30 | 500.00M shares 10-Q · filed 2024-11-13 |
| 2024-06-30 | 500.00M shares 10-Q · filed 2024-08-13 |
| 2024-03-31 | 500.00M shares 10-Q · filed 2024-05-14 |
| 2023-12-31 | 500.00M shares 10-K · filed 2025-03-26 |
| 2023-09-30 | 500.00M shares 10-Q · filed 2023-11-08 |
| 2023-06-30 | 500.00M shares 10-Q · filed 2023-08-09 |
| 2023-03-31 | 500.00M shares 10-Q · filed 2023-05-10 |
| 2022-12-31 | 500.00M shares 10-K · filed 2024-03-28 |
| 2022-09-30 | 500.00M shares 10-Q · filed 2022-11-09 |
| 2022-06-30 | 500.00M shares 10-Q · filed 2022-08-09 |
| 2022-03-31 | 500.00M shares 10-Q · filed 2022-05-10 |
| 2021-12-31 | 500.00M shares 10-K · filed 2023-03-16 |
| 2021-11-12 | 500.00M shares 10-K · filed 2023-03-16 |
| 2020-11-06 | 400.00K shares 10-K · filed 2022-03-11 |
| 2018-09-10 | 20.00K shares 10-K · filed 2022-03-11 |